Related Experiment Video
Updated: Jun 22, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Unmet needs in rheumatoid arthritis
1Mount Sinai Hospital, Joseph and Wolfe Lebovic Building, 60 Murray Street, Main Floor, Room 2-005, Toronto, Ontario M5G 1X5. VBykerk@mtsinai.on.ca
The Journal of Rheumatology. Supplement
|June 11, 2009
Summary
Early diagnosis and prognostic markers are crucial for rheumatoid arthritis (RA) treatment. Identifying patients needing aggressive strategies can improve remission rates and reduce work absences in RA care.
Area of Science:
- Rheumatology
- Clinical Medicine
- Immunology
Background:
- Rheumatoid arthritis (RA) treatment advances, including biologics and combination DMARDs, have not fully optimized remission rates.
- Suboptimal remission impacts patient workdays, highlighting the need for improved RA management strategies.
Purpose of the Study:
- To emphasize the need for early diagnostic criteria in rheumatoid arthritis (RA) to enable timely treatment and prevent joint damage.
- To highlight the necessity of better prognostic markers for identifying RA patients with poor outcomes, guiding aggressive initial therapy.
Main Methods:
- The abstract discusses the limitations of current clinical trial generalizability to real-world RA practice.
- It notes the absence of predictive biomarkers for RA disease course, leading to methotrexate as a common initial treatment.
Main Results:
- Current rheumatoid arthritis (RA) treatment guidelines may not fully reflect clinical practice due to trial limitations.
- Methotrexate remains a standard initial therapy for RA in the absence of predictive biomarkers.
Conclusions:
- Improved prognostic markers for rheumatoid arthritis (RA) could enable targeted therapies and increase remission rates.
- Developing better diagnostic and prognostic tools is essential for optimizing RA patient outcomes and reducing disease burden.
Related Concept Videos
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...